Inovio Pharmaceuticals Inc
INO
Company Profile
Business description
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Contact
660 West Germantown Pike
Suite 110
Plymouth MeetingPA19462
USAT: +1 267 440-4200
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
134
Stocks News & Analysis
stocks
Looking under the hood at Robinhood
We review some of the platform's most popular stocks on 11 different measures of equity-related risk.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,690.90 | 53.40 | 0.62% |
| CAC 40 | 7,706.08 | 31.12 | -0.40% |
| DAX 40 | 23,872.81 | 57.86 | -0.24% |
| Dow JONES (US) | 42,305.48 | 35.41 | 0.08% |
| FTSE 100 | 8,746.22 | 28.04 | -0.32% |
| HKSE | 23,512.49 | 354.52 | 1.53% |
| NASDAQ | 19,242.61 | 128.85 | 0.67% |
| Nikkei 225 | 37,446.81 | 23.86 | -0.06% |
| NZX 50 Index | 12,327.23 | 91.66 | -0.74% |
| S&P 500 | 5,935.94 | 24.25 | 0.41% |
| S&P/ASX 200 | 8,466.70 | 52.60 | 0.63% |
| SSE Composite Index | 3,361.98 | 14.49 | 0.43% |